The development of prognostic and predictive biomarkers in renal cell cancer are not one and the same thing

Affiliations

¹ MRC Human Genetics Unit, University of Edinburgh, Edinburgh, UK; Edinburgh Urological Cancer Group, University of Edinburgh, Edinburgh, UK; Scottish Collaboration On Translational Research into Renal Cell Cancer, Scotland, UK. Electronic address: alex.laird@ed.ac.uk.
² Scottish Collaboration On Translational Research into Renal Cell Cancer, Scotland, UK; School of Medicine, University of St. Andrews, St. Andrews, UK.
³ Edinburgh Urological Cancer Group, University of Edinburgh, Edinburgh, UK; Scottish Collaboration On Translational Research into Renal Cell Cancer, Scotland, UK.

Editorial

Alexander Laird et al. Eur Urol. 2015 Jan.

. 2015 Jan;67(1):21-22.

doi: 10.1016/j.eururo.2014.07.037. Epub 2014 Aug 11.

¹ MRC Human Genetics Unit, University of Edinburgh, Edinburgh, UK; Edinburgh Urological Cancer Group, University of Edinburgh, Edinburgh, UK; Scottish Collaboration On Translational Research into Renal Cell Cancer, Scotland, UK. Electronic address: alex.laird@ed.ac.uk.
² Scottish Collaboration On Translational Research into Renal Cell Cancer, Scotland, UK; School of Medicine, University of St. Andrews, St. Andrews, UK.
³ Edinburgh Urological Cancer Group, University of Edinburgh, Edinburgh, UK; Scottish Collaboration On Translational Research into Renal Cell Cancer, Scotland, UK.

No abstract available

Comment on

A multigene assay identifying distinct prognostic subtypes of clear cell renal cell carcinoma with differential response to tyrosine kinase inhibition.
Choudhury Y, Wei X, Chu YH, Ng LG, Tan HS, Koh V, Thike AA, Poon E, Ng QS, Toh CK, Kanesvaran R, Tan PH, Tan MH. Choudhury Y, et al. Eur Urol. 2015 Jan;67(1):17-20. doi: 10.1016/j.eururo.2014.06.041. Epub 2014 Jul 10. Eur Urol. 2015. PMID: 25018036